22 employees
Cargene is a preclinical-stage biopharmaceutical company developing oligonucleotide therapeutics across a broad range of diseases.
2020
$19M
from 2 investors over 2 rounds
Cargene Therapeutics raised $19M on December 14, 2021
Investors: 博远资本 and Lengend Star